» Authors » G W Staton Jr

G W Staton Jr

Explore the profile of G W Staton Jr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 124
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gal A, Salinas F, Staton Jr G
Arch Pathol Lab Med . 1994 Dec; 118(12):1209-14. PMID: 7979916
Antineutrophil cytoplasmic autoantibodies (ANCAs), classified as either perinuclear (P-ANCAs) or cytoplasmic (C-ANCAs), have been recently recognized as important markers for the diagnosis and monitoring of systemic vasculitic disorders. The purpose...
2.
Perez R, Roman J, Staton Jr G, Hunter R
Am J Respir Crit Care Med . 1994 Feb; 149(2 Pt 1):510-8. PMID: 8306054
Diffuse pulmonary inflammation in interstitial lung diseases is associated with increased coagulation in the extravascular spaces of the lung. We hypothesized that conditions favoring coagulation over fibrinolysis in the lung...
3.
Behling C, Perez R, Kidd M, Staton Jr G, Hunter R
Ann Clin Lab Sci . 1993 Jul; 23(4):256-66. PMID: 8373130
Trehalose 6,6' dimycolate (TDM), a mycobacterial glycolipid, induces granulomas and hemorrhagic toxic reactions when administered in oil but not as a suspension in saline. It was previously demonstrated by us...
4.
Perez R, Duncan A, Hunter R, Staton Jr G
Chest . 1993 Apr; 103(4):1100-6. PMID: 8131447
The hypothesis of this study was that D dimer, a specific degradation product of cross-linked fibrin, would be increased in the bronchoalveolar lavage (BAL) fluids of patients with sarcoidosis and...
5.
Perez R, Jeon Y, Staton Jr G, Roman J
Chest . 1993 Feb; 103(2 Suppl):86S-87S. PMID: 8381346
No abstract available.
6.
Aguayo S, Miller Y, Waldron Jr J, Bogin R, Sunday M, Staton Jr G, et al.
N Engl J Med . 1992 Nov; 327(18):1285-8. PMID: 1406819
No abstract available.
7.
Perez R, Staton Jr G
J Med Assoc Ga . 1991 Oct; 80(10):523-8. PMID: 1744519
Interstitial lung diseases pose a great challenge to the clinician because of the indolent and variably active nature of these disorders and the limited number of therapeutic options. Adjunctive therapy...
8.
Staton Jr G, Check I, Fajman W, Gilman M, Pine J
Sarcoidosis . 1987 Mar; 4(1):8-12. PMID: 3589196
The use of unilateral lobar bronchoalveolar lavage (BAL) to assess disease activity in pulmonary sarcoidosis assumes that the alveolitis is homogeneous throughout the lung parenchyma. Three studies were used to...
9.
Brougher L, Blackwelder A, Grossman G, Staton Jr G
Chest . 1986 Nov; 90(5):646-8. PMID: 3769563
Concern for the rising costs of respiratory therapy in patient care caused a third party payor to implement reimbursement guidelines for inhospital delivery of oxygen (O2) therapy. While these guidelines...
10.
Staton Jr G, Gilman M, Pine J, Fajman W, Check I
Sarcoidosis . 1986 Mar; 3(1):10-8. PMID: 3033784
A major problem in pulmonary sarcoidosis is the assessment of disease activity. We established a clinical score system composed of degree of dyspnea, chest radiographic stage, forced vital capacity, and...